Severity
Critical
CriticalClass ITerminated
FDA Food recall · Reported June 19, 2013
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
Undeclared Soy and Milk on the label.
Atlantic Pro Nutrients, Inc. dba Xymogen recalled XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support H… - a critical-severity action.
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support H… was recalled by Atlantic Pro Nutrients, Inc. dba Xymogen in June 19, 2013. Reason: Undeclared Soy and Milk on the label.. Check the official notice for the remedy. Verify recall #F-1523-2013 with the FDA Food before acting.
The recall
Atlantic Pro Nutrients, Inc. dba Xymogen issued this critical-severity FDA Food recall-Undeclared Soy and Milk on the label..
- Critical
- severity level
- 16K units
- affected scope
- Class I
- classification
- June 19, 2013
- reported
Sourced from official FDA Food enforcement records. Verify recall #F-1523-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This FDA Food action (record #F-1523-2013) was formally reported on June 19, 2013, with the manufacturer initiating the action on May 1, 2013. It is classified under Critical severity (Class I), with a current status of Terminated. Atlantic Pro Nutrients, Inc. dba Xymogen is listed as the recalling firm, operating out of Orlando, FL. Federal records list the affected scope as 16,268 units.
The documented reason for this recall is: Undeclared Soy and Milk on the label. Distribution data in the federal record shows the product reached: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 1 from FDA Food - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Drugs & Medications recalls over time
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Affected scope
16,268 units
Related Recalls
6
1 from same agency
Product description
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
Reason for recall
Undeclared Soy and Milk on the label.
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | F-1523-2013 |
| Date reported | June 19, 2013 |
| Date initiated | May 1, 2013 |
| Recalling firm | Atlantic Pro Nutrients, Inc. dba Xymogen |
| Firm location | Orlando, FL |
| Affected scope | 16,268 units |
| Distribution | AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii |
Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
- Check the recall number (F-1523-2013) and product description against the item you own. Search the archive
- Confirm the current status with FDA Food before acting, recall details can be updated.
- This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next
This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles. Recalled by Atlantic Pro Nutrients, Inc. dba Xymogen. Units affected: 16,268 units.
Why was this product recalled? ▼
Undeclared Soy and Milk on the label.
Which agency issued this recall? ▼
This recall was issued by the FDA Food on June 19, 2013. Severity: Critical. Recall number: F-1523-2013.
Where was the recalled product distributed? ▼
Distribution: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (F-1523-2013) against your product. Visit the official FDA Food website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
What are the health risks of consuming a recalled food product? ▼
Recalled food products may contain contaminants, undeclared allergens, or harmful bacteria such as Salmonella, Listeria, or E. coli. Consuming these products can cause foodborne illness ranging from mild gastrointestinal symptoms to serious conditions requiring hospitalization. If you have consumed a recalled food product and experience symptoms, contact your healthcare provider and report to the FDA via MedWatch.
Nearby Recalls in This Category
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
FDA Drug Low
PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie c…
AbbVie Inc. · 2026-06-03
FDA Food Moderate
Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement, Net Wt. 8 FL Oz (237mL) Amber PET modern round 24-400 bot…
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
FDA Drug Moderate
Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by:…
Safecor Health, LLC · 2026-05-27
FDA Drug Moderate
fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3…
IntegraDose Compounding Services LLC · 2026-05-27
FDA Drug Moderate
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, …
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Food, reported June 19, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.